Search
Feed aggregator
Merck’s Keytruda Continues NSCLC Losing Streak with Phase III Flop
Merck’s Keytruda Continues NSCLC Losing Streak with Phase III Flop 3/21/2024
Mirador Launches with $400M in Funding, Targets Precision Medicines
Mirador Launches with $400M in Funding, Targets Precision Medicines 3/21/2024
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO 3/21/2024
Money Talk: Salary Trends and Raises
Money Talk: Salary Trends and Raises 3/21/2024
Bayer Eliminates Nearly Half of Its Executive Positions in Major Overhaul
Bayer Eliminates Nearly Half of Its Executive Positions in Major Overhaul 3/21/2024
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug 3/21/2024
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS 3/21/2024
New Graduates Struggle in Current Biopharma Job Market
New Graduates Struggle in Current Biopharma Job Market 3/21/2024
Top 5 Remote Quality-Control Jobs
Top 5 Remote Quality-Control Jobs 3/21/2024
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help identify patients who may benefit from Bayer's growing portfolio of precision cancer therapies by offering decentralized genomic testing and rapid turnaround time.
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval 3/20/2024
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche 3/20/2024
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B 3/20/2024
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers 3/20/2024
Historic Approval for MASH, CAR-Ts in the Spotlight
Historic Approval for MASH, CAR-Ts in the Spotlight 3/20/2024
What Another Trump Presidency Could Mean for Big Pharma
What Another Trump Presidency Could Mean for Big Pharma 3/20/2024
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label 3/20/2024
How to Talk About Politics at Work
How to Talk About Politics at Work 3/20/2024
Novo Invests $556M in China Operations to Boost Manufacturing Capacity
Novo Invests $556M in China Operations to Boost Manufacturing Capacity 3/20/2024
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA 3/20/2024
World Pharma News
- U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B
- AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
- Researchers publish final results of key clinical trial for gene therapy for sickle cell disease
- Optimal timing maximises Paxlovid benefits for treating COVID-19
- European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options